Skip to content
naulon
Not checkedNot checked for notices yet.

Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants

Kyoung Oh Kim

The Korean Journal of Helicobacter and Upper Gastrointestinal Research · 2016

doi:10.7704/kjhugr.2016.16.4.185 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Anticoagulant agents are used to reduce the risk of thromboembolic complications in patients with atrial fibrillation or deep vein thrombosis. Several new generation of oral anticoagulants have been approved. These novel oral anticoagulants (NOACs) include direct thrombin inhibitors, dabigatra etexilate, and the direct factor Xa inhibitors, rivaroxaban, apixaban and edoxaban. This review evaluates NOACs-related gastrointestinal bleeding and summarizes the ideal management strategies based on the guideline suggested by American Society for Gastrointestinal Endoscopy.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.